These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7482743)

  • 1. Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11).
    Henrickson M; Reid J; Bellet JS; Sawchuk SS; Hirsch R
    Transplantation; 1995 Oct; 60(8):828-35. PubMed ID: 7482743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of allograft rejection by anti-T-cell receptor-alpha beta monoclonal antibodies preserving resistance to bacterial infection.
    Eto M; Yoshikai Y; Nishimura Y; Hiromatsu K; Maeda T; Nomoto K; Kong YY; Kubo RT; Kumazawa J; Nomoto K
    Immunology; 1994 Feb; 81(2):198-204. PubMed ID: 8157269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity.
    Alegre ML; Tso JY; Sattar HA; Smith J; Desalle F; Cole M; Bluestone JA
    J Immunol; 1995 Aug; 155(3):1544-55. PubMed ID: 7636216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Kobayashi N; Nomoto K; Kong YY; Nomoto K
    Immunology; 1994 Oct; 83(2):196-204. PubMed ID: 7835935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
    Hirsch R; Archibald J; Gress RE
    J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting in vivo effects on T helper cell functions induced by mitogenic (intact) versus nonmitogenic (F(ab')2) anti-CD3 monoclonal antibody.
    Sawchuk SS; Gates R; Hirsch R
    Transplantation; 1995 Dec; 60(11):1331-7. PubMed ID: 8525530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo or in vitro anti-CD3 epsilon chain monoclonal antibody therapy for the prevention of lethal murine graft-versus-host disease across the major histocompatibility barrier in mice.
    Blazar BR; Taylor PA; Vallera DA
    J Immunol; 1994 Apr; 152(7):3665-74. PubMed ID: 8144942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells.
    Hirsch R; Gress RE; Pluznik DH; Eckhaus M; Bluestone JA
    J Immunol; 1989 Feb; 142(3):737-43. PubMed ID: 2521507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of anti-T-cell receptor alpha beta monoclonal antibody-induced side-effects by treatment with cyclosporin A without interference of monoclonal antibody-induced immunosuppression in mice.
    Murakami Y; Kong YY; Nishimura Y; Nomoto K; Umesue M; Omoto K; Maeda T; Nomoto K
    Immunology; 1995 Oct; 86(2):238-43. PubMed ID: 7490124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice.
    Hirsch R; Bluestone JA; Bare CV; Gress RE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):270-1. PubMed ID: 1824981
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
    Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
    Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD3 epsilon F(ab')2 fragments inhibit T cell expansion in vivo during graft-versus-host disease or the primary immune response to nominal antigen.
    Blazar BR; Jenkins MK; Taylor PA; White J; Panoskaltsis-Mortari A; Korngold R; Vallera DA
    J Immunol; 1997 Dec; 159(12):5821-33. PubMed ID: 9550378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo immunosuppression induced by a weakly mitogenic antibody to mouse CD3: evidence that induction of long-lasting in vivo unresponsiveness requires TcR signaling.
    Flamand V; Donckier V; Abramowicz D; Goldman M; Vandenabeele P; Urbain J; Moser M; Leo O
    Cell Immunol; 1994 Aug; 157(1):239-48. PubMed ID: 8039247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR; Taylor PA; Snover DC; Bluestone JA; Vallera DA
    J Immunol; 1993 Jan; 150(1):265-77. PubMed ID: 8417127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD2 monoclonal antibody-induced receptor changes: down modulation of cell surface CD2.
    Lin J; Yon RW; Chavin KD; Qin L; Woodward J; Ding Y; Yagita H; Bromberg JS
    Transplantation; 1995 Apr; 59(8):1162-71. PubMed ID: 7537394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CD2 monoclonal antibody-induced receptor changes. II. Interaction of CD2 and CD3.
    Lin J; Chavin KD; Qin L; Ding Y; Bromberg JS
    Cell Immunol; 1996 Feb; 167(2):249-58. PubMed ID: 8603434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient CD4+ T cell proliferation in the class 1 MHC-restricted 2C TCR-transgenic mouse.
    Chen FL; Kung JT
    J Immunol; 1996 Mar; 156(6):2036-44. PubMed ID: 8690890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
    Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.
    Nomoto K; Yung-Yun K; Omoto K; Umesue M; Murakami Y; Matsuzaki G; Nomoto K
    Transplantation; 1995 Feb; 59(3):395-401. PubMed ID: 7871570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.